Eli Lilly
2 articles

Cosmos & Space
Eli Lilly Obesity Drug Causes Widespread Gut Issues
Nearly half of the 70,000 GLP-1 drug users surveyed reported at least one side effect.
Marcus Cole·June 26, 2026

Cosmos & Space
Eli Lilly invests in AI startup Absci for new hair loss treatments
Despite 71% of adolescents with severe alopecia achieving successful hair regrowth with its existing drug, Eli Lilly is now betting on an early-stage AI startup for hair loss treatments.
Marcus Cole·June 25, 2026